ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Authorization Bill Passes Senate 82-0

June 27, 1980

Mass. ACS Offers Three Programs For Young Investigators

July 24, 1987

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Two Court Rulings Conflict In Paclitaxel Patent Battle.

January 18, 2002

NCI’s Robert Wittes Named Physician-In-Chief, Memorial Sloan-Kettering Cancer Center.

December 7, 2001